Skip to main content
. 2020 Jun;9(3):934–943. doi: 10.21037/tlcr-2019-pps-10

Figure 2.

Figure 2

Concordant immunophenotype of malignant mesothelioma by immunohistochemistry (IHC) seen in histological material (column 1), and by immunocytochemistry (ICC) in effusion cytology rich in papillary groups (column 2) and effusion cytology with completely dissociated cells (column 3). Row 1: routine stain (Hematoxylin and eosin and Papanicolaou stains, respectively). Row 2: Calretinin reactivity, cytology specimen with Calretinin (red)/BerEp4 (brown) double stain. Row 3: EMA reactivity, cytology specimen with EMA (red)/Desmin (brown) double stain). The few scattered reactive mesothelial cells in the background are double positive for Calretinin (red, row 2) and Desmin (brown, row 3). Row 4: Podoplanin (D2-40). Row 5: WT1. Magnification: 400×.